Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 472.45
+8.35 (1.80%)
Nov 12, 2026, 3:30 PM IST
Cohance Lifesciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,078 | 491.4 | 966.5 | 472.3 | 648.03 | 445.64 |
Short-Term Investments | 1,851 | 46.6 | 94.7 | - | - | - |
Trading Asset Securities | - | 2,663 | 1,917 | 7,739 | 4,189 | 4,812 |
Cash & Short-Term Investments | 2,929 | 3,201 | 2,979 | 8,211 | 4,837 | 5,258 |
Cash Growth | -26.86% | 7.47% | -63.73% | 69.75% | -8.00% | 180.01% |
Accounts Receivable | 4,690 | 7,014 | 7,883 | 1,337 | 1,109 | 2,364 |
Other Receivables | 240.5 | 1,631 | 1,585 | 562.3 | 665.92 | 480.04 |
Receivables | 4,953 | 8,724 | 9,493 | 1,907 | 1,777 | 2,846 |
Inventory | 7,343 | 5,622 | 4,674 | 2,332 | 3,306 | 3,000 |
Prepaid Expenses | - | 248.9 | 207.9 | 49.2 | 86.28 | 64 |
Other Current Assets | 2,183 | 482.8 | 582 | 32.7 | 103.79 | 111.67 |
Total Current Assets | 17,408 | 18,280 | 17,935 | 12,532 | 10,110 | 11,279 |
Property, Plant & Equipment | 21,590 | 21,633 | 20,964 | 7,868 | 7,662 | 5,620 |
Long-Term Investments | 2,659 | 2,645 | 1,458 | 1,306 | 1,171 | 1,171 |
Goodwill | 12,902 | 12,837 | 12,390 | 602.5 | 602.58 | - |
Other Intangible Assets | 1,661 | 995.2 | 1,064 | 16.8 | 19.32 | 22.36 |
Long-Term Deferred Tax Assets | 15.9 | 26.4 | 5.5 | 8.1 | - | - |
Other Long-Term Assets | 565.6 | 867.7 | 885.4 | 216 | 91.64 | 203.02 |
Total Assets | 56,802 | 57,296 | 54,810 | 22,549 | 19,657 | 18,296 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 3,643 | 2,846 | 2,684 | 423.5 | 700.92 | 1,059 |
Accrued Expenses | - | 938.9 | 1,021 | 256.9 | 128.17 | 266 |
Short-Term Debt | 1,996 | 744.3 | 706.5 | 385.8 | 445.98 | 471.33 |
Current Portion of Long-Term Debt | - | 447.6 | 579.6 | - | 200 | 200 |
Current Portion of Leases | 248.6 | 252.5 | 364.5 | 51.9 | 4.79 | 10.91 |
Current Income Taxes Payable | 171.4 | 164.4 | 75.2 | - | 2.94 | 36.42 |
Current Unearned Revenue | - | 247.1 | 43 | 6.9 | 8.08 | - |
Other Current Liabilities | 2,595 | 818.7 | 1,580 | 49 | 96.79 | 59.27 |
Total Current Liabilities | 8,654 | 6,459 | 7,054 | 1,174 | 1,588 | 2,103 |
Long-Term Debt | 281 | 504.8 | 1,298 | - | 45.64 | 284.4 |
Long-Term Leases | 1,959 | 2,056 | 1,911 | 212.4 | 7 | 4.63 |
Pension & Post-Retirement Benefits | - | 4 | 2.6 | - | - | 11.09 |
Long-Term Deferred Tax Liabilities | 998.4 | 979 | 1,026 | 656 | 582.35 | 543.15 |
Other Long-Term Liabilities | 5,041 | 6,955 | 5,590 | - | 82.95 | 77.85 |
Total Liabilities | 16,933 | 16,958 | 16,881 | 2,042 | 2,306 | 3,024 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 382.6 | 382.6 | 254.6 | 254.6 | 254.57 | 254.57 |
Additional Paid-In Capital | - | 2,722 | 2,694 | 1,096 | 1,096 | 1,096 |
Retained Earnings | - | 24,001 | 22,150 | 18,894 | 15,894 | 13,820 |
Comprehensive Income & Other | 38,739 | 12,007 | 11,389 | 262.3 | 107.17 | 101.65 |
Total Common Equity | 39,122 | 39,113 | 36,488 | 20,507 | 17,352 | 15,272 |
Minority Interest | 746.6 | 1,225 | 1,441 | - | - | - |
Shareholders' Equity | 39,869 | 40,338 | 37,929 | 20,507 | 17,352 | 15,272 |
Total Liabilities & Equity | 56,802 | 57,296 | 54,810 | 22,549 | 19,657 | 18,296 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 4,484 | 4,005 | 4,859 | 650.1 | 703.41 | 971.27 |
Net Cash (Debt) | -1,555 | -803.7 | -1,881 | 7,561 | 4,134 | 4,287 |
Net Cash Growth | - | - | - | 82.90% | -3.56% | 858.10% |
Net Cash Per Share | -4.04 | -2.10 | -4.90 | 29.70 | 16.24 | 16.84 |
Filing Date Shares Outstanding | 380.5 | 382.57 | 382.57 | 254.56 | 254.56 | 254.56 |
Total Common Shares Outstanding | 380.5 | 382.57 | 254.56 | 254.56 | 254.56 | 254.56 |
Working Capital | 8,754 | 11,820 | 10,881 | 11,358 | 8,523 | 9,176 |
Book Value Per Share | 102.82 | 102.24 | 143.34 | 80.56 | 68.16 | 59.99 |
Tangible Book Value | 24,559 | 25,281 | 23,035 | 19,887 | 16,730 | 15,249 |
Tangible Book Value Per Share | 64.54 | 66.08 | 90.49 | 78.12 | 65.72 | 59.90 |
Land | - | 797.8 | 827.2 | 150.5 | 150.46 | 150.46 |
Buildings | - | 6,278 | 5,197 | 2,206 | 2,200 | 1,813 |
Machinery | - | 17,234 | 14,697 | 5,797 | 5,410 | 4,750 |
Construction In Progress | - | 1,732 | 3,316 | 1,790 | 1,651 | 299.94 |
Leasehold Improvements | - | 267.8 | 252.3 | 42.6 | - | - |